The companies receiving the funding are BioNanovations, EcoSurg, Nanophthalmics and Urova Medical.
It is the second round of funding for the companies. In return for an equity stake, each participating company in the accelerator program initially received a $50,000 investment to work on developing a business plan and designing prototypes of devices. In August, the companies presented their products to potential investors and were selected to receive the additional $100,000 investment, for an incremental equity stake.
With the additional funding, the companies will take prototypes through the next phase of development, and focus on meeting the FDA regulatory requirements for a 510(k) filing, according to the accelerator program’s website.
Related Articles on New Technology:
Zynex Receives FDA Clearance for Female Urinary Incontinence Device
Johns Hopkins Students Develop Suture Guide Tool
AngioDynamics receives FDA Clearance for Peripherally Inserted Central Catheter
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.